COVID-19 was the most studied condition in clinical trials during 2020-21, a new analysis from the patient empowerment organization With Power found.
The organization evaluated clinical trial data from the U.S. National Library of Medicine during the past decade to identify what conditions were being studied and where those studies were being conducted.
The analysis of the data found that more than 700 clinical trials were stopped due to the pandemic in 2020-21.
Read more at Newsmax© 2022 Newsmax. All rights reserved.